Technology | 2022.09.26
Aktiv Pharma Group to Participate in the FDA Emerging Technology Program
Aktiv Pharma Group's novel glass-free primary drug container technology for sterile injectable pharmaceutical products has been accepted into the Federal Food and Drug Administration (FDA) Emerging Technology Program.
(PRWeb September 26, 2022)
Read the full story at https://www.prweb.com/releases/2022/09/prweb18919146.htm
For more information, please visit
https://www.prweb.com/releases/2022/09/prweb18919146.htm
Follow us on
Instagram is adding automatic in-app text translation - The Verge views: 1570
Instagram is adding automatic in-app text translation - The Verge views: 1507